Drug Discovery News and Research

RSS
The drug discovery process begins with recognizing a disease or clinical condition in which there is a lack of adequate medical treatment. Once a potential drug has been identified, pre-clinical research can begin. This process includes several stages; the first of which involves identifying and validating the prospective drug’s target through assay development, high throughput screening, hit identification and finally, lead optimization. Once the pre-clinical process is complete, the newly synthesized drug candidate is selected for future clinical development.
Bio-Quant to be acquired by NexMed

Bio-Quant to be acquired by NexMed

ASTMH symposium illustrates the need to generate new medicines for infectious diseases

ASTMH symposium illustrates the need to generate new medicines for infectious diseases

Alzheimer Research Forum reports on the highlights of the Society of Neuroscience conference

Alzheimer Research Forum reports on the highlights of the Society of Neuroscience conference

CDAS, Prestwick Chemical sign drug discovery research agreement

CDAS, Prestwick Chemical sign drug discovery research agreement

Ligand Pharmaceuticals receives $2 million in milestone payments from N. V. Organon

Ligand Pharmaceuticals receives $2 million in milestone payments from N. V. Organon

Ligon Discovery raises $1 million

Ligon Discovery raises $1 million

Halifax researcher wins Prix Galien Research Award

Halifax researcher wins Prix Galien Research Award

Pfizer and DNDi to battle against HAT, VL and Chagas disease

Pfizer and DNDi to battle against HAT, VL and Chagas disease

Asterand to acquire BioSeek

Asterand to acquire BioSeek

AACR-NCI-EORTC conference highlights major expansion in cancer drug pipeline

AACR-NCI-EORTC conference highlights major expansion in cancer drug pipeline

LEAD Therapeutics discovers orally available PARP inhibitor

LEAD Therapeutics discovers orally available PARP inhibitor

deCODE genetics files voluntary petition for relief under Chapter 11 of the United States Bankruptcy Code

deCODE genetics files voluntary petition for relief under Chapter 11 of the United States Bankruptcy Code

PPD, Janssen Pharmaceutica to develop therapeutic compounds for IBS and bacterial infections

PPD, Janssen Pharmaceutica to develop therapeutic compounds for IBS and bacterial infections

4SC raises funds for further development of its current product pipeline

4SC raises funds for further development of its current product pipeline

Fate Therapeutics announces the completion of $30 million Series B financing

Fate Therapeutics announces the completion of $30 million Series B financing

Potential of the European Biomarker Analysis Market to be the focus at upcoming Analyst Briefing

Potential of the European Biomarker Analysis Market to be the focus at upcoming Analyst Briefing

Amorfix Life Sciences reports operating results for the three months ended September 30, 2009

Amorfix Life Sciences reports operating results for the three months ended September 30, 2009

Nutra Pharma to market its OTC pain reliever in Brazil and Colombia, begins the drug registration process

Nutra Pharma to market its OTC pain reliever in Brazil and Colombia, begins the drug registration process

Update on Alnylam Pharmaceuticals' RNAi pipeline, platform, and technology

Update on Alnylam Pharmaceuticals' RNAi pipeline, platform, and technology

Stapled Peptides directly inhibit the Notch transcription factor complex

Stapled Peptides directly inhibit the Notch transcription factor complex

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.